Twenty-five flavors coral capsule
Function and Efficacy
Oral administration of this product can significantly prolong the survival time of mice with cerebral circulatory disorder and hypoxia caused by carotid artery ligation, and reduce the whole blood viscosity of rats with blood stasis model induced by subcutaneous injection of isoproterenol and ice water stimulation; it can reduce the mortality of mice with collagen-epinephrine-induced thrombosis in vivo; it can increase the pain threshold of mice induced by the hot plate method; in the animal model of migraine induced by subcutaneous injection of reserpine and puncture of the skull to about 1-2mm below the right cerebral cortex and injection of mouse whole blood, both preventive and therapeutic administration can significantly reduce the mouse brain coefficient and improve the absorption of cerebral blood clots. The long-term toxicity test of continuous administration for 3 months showed that starting from the 6th week after administration, a few animals in the three dose groups (0.495, 0.99, 1.98g crude drug/kg) of this product showed salivation when administered by gavage, and the symptoms disappeared after drug withdrawal; 3 months after administration, the hemoglobin content of the three dose groups of this product was lower than that of the control group, and 3 weeks after drug withdrawal, the granulocyte count in the low dose group was lower than that of the control group; 3 months after administration, the testicular coefficient in the low dose group was lower than that of the control group; pathological histological examination showed that 3 months after administration, one rat in the high dose group showed degeneration of the seminiferous tubules.
Ingredients
Fragrances include coral, terminalia chebula, costusroot, brain stone, licorice, clove, dragon bone, safflower, iron hammer (processed), pearl, artificial musk, cinnabar, etc.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| 2-Naphthaleneacetic acid, 1,2,3,4,4a,5,6,7-octahydro-4a,8-dimethyl-α-methylene-7-oxo-Ingredients |
Oral administration of this product can significantly prolong the survival time of mice with cerebral circulatory disorder and hypoxia caused by carotid artery ligation, and reduce the whole blood viscosity of rats with blood stasis model induced by subcutaneous injection of isoproterenol and ice water stimulation; it can reduce the mortality of mice with collagen-epinephrine-induced thrombosis in vivo; it can increase the pain threshold of mice induced by the hot plate method; in the animal model of migraine induced by subcutaneous injection of reserpine and puncture of the skull to about 1-2mm below the right cerebral cortex and injection of mouse whole blood, both preventive and therapeutic administration can significantly reduce the mouse brain coefficient and improve the absorption of cerebral blood clots. The long-term toxicity test of continuous administration for 3 months showed that starting from the 6th week after administration, a few animals in the three dose groups (0.495, 0.99, 1.98g crude drug/kg) of this product showed salivation when administered by gavage, and the symptoms disappeared after drug withdrawal; 3 months after administration, the hemoglobin content of the three dose groups of this product was lower than that of the control group, and 3 weeks after drug withdrawal, the granulocyte count in the low dose group was lower than that of the control group; 3 months after administration, the testicular coefficient in the low dose group was lower than that of the control group; pathological histological examination showed that 3 months after administration, one rat in the high dose group showed degeneration of the seminiferous tubules. More |
1083197-66-3 | 0 | |
| Clove oilIngredients |
Oral administration of this product can significantly prolong the survival time of mice with cerebral circulatory disorder and hypoxia caused by carotid artery ligation, and reduce the whole blood viscosity of rats with blood stasis model induced by subcutaneous injection of isoproterenol and ice water stimulation; it can reduce the mortality of mice with collagen-epinephrine-induced thrombosis in vivo; it can increase the pain threshold of mice induced by the hot plate method; in the animal model of migraine induced by subcutaneous injection of reserpine and puncture of the skull to about 1-2mm below the right cerebral cortex and injection of mouse whole blood, both preventive and therapeutic administration can significantly reduce the mouse brain coefficient and improve the absorption of cerebral blood clots. The long-term toxicity test of continuous administration for 3 months showed that starting from the 6th week after administration, a few animals in the three dose groups (0.495, 0.99, 1.98g crude drug/kg) of this product showed salivation when administered by gavage, and the symptoms disappeared after drug withdrawal; 3 months after administration, the hemoglobin content of the three dose groups of this product was lower than that of the control group, and 3 weeks after drug withdrawal, the granulocyte count in the low dose group was lower than that of the control group; 3 months after administration, the testicular coefficient in the low dose group was lower than that of the control group; pathological histological examination showed that 3 months after administration, one rat in the high dose group showed degeneration of the seminiferous tubules. More |
8000-34-8 | 4 | |
| Mercury(II) sulfideIngredients |
Oral administration of this product can significantly prolong the survival time of mice with cerebral circulatory disorder and hypoxia caused by carotid artery ligation, and reduce the whole blood viscosity of rats with blood stasis model induced by subcutaneous injection of isoproterenol and ice water stimulation; it can reduce the mortality of mice with collagen-epinephrine-induced thrombosis in vivo; it can increase the pain threshold of mice induced by the hot plate method; in the animal model of migraine induced by subcutaneous injection of reserpine and puncture of the skull to about 1-2mm below the right cerebral cortex and injection of mouse whole blood, both preventive and therapeutic administration can significantly reduce the mouse brain coefficient and improve the absorption of cerebral blood clots. The long-term toxicity test of continuous administration for 3 months showed that starting from the 6th week after administration, a few animals in the three dose groups (0.495, 0.99, 1.98g crude drug/kg) of this product showed salivation when administered by gavage, and the symptoms disappeared after drug withdrawal; 3 months after administration, the hemoglobin content of the three dose groups of this product was lower than that of the control group, and 3 weeks after drug withdrawal, the granulocyte count in the low dose group was lower than that of the control group; 3 months after administration, the testicular coefficient in the low dose group was lower than that of the control group; pathological histological examination showed that 3 months after administration, one rat in the high dose group showed degeneration of the seminiferous tubules. More |
1344-48-5 | 0 |
Appearance
This product is a capsule, the contents of which are brown-yellow powder; it has a slight fragrance and tastes sweet, bitter and astringent.
Usage and Dosage
Oral administration: 2 capsules at a time, once a day.
Adverse Reactions
Not yet clear.
Precautions
Not yet clear.
Drug Interactions
Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details.
Storage
Sealed and moisture-proof.
Packaging Specification
0.5g per capsule
Validity Period
24 months
Manufacturer
Xizang Jinzhuyalong Xizangan Medicine Co., Ltd.
-
Founded in:
2001-05-11 -
Address:
No. 78, Naidong Road, Zetang Town, Naidong District, Shannan City, Tibet Autonomous Region -
Tax NO.:
9154220071091160XC -
Registered Funds:
11.3433 million yuan -
Website:
-
Email: